[go: up one dir, main page]

WO1998023260A3 - Vesicules de tensioactifs non ioniques en tant qu'agent de transport d'acide nucleique - Google Patents

Vesicules de tensioactifs non ioniques en tant qu'agent de transport d'acide nucleique Download PDF

Info

Publication number
WO1998023260A3
WO1998023260A3 PCT/GB1997/003235 GB9703235W WO9823260A3 WO 1998023260 A3 WO1998023260 A3 WO 1998023260A3 GB 9703235 W GB9703235 W GB 9703235W WO 9823260 A3 WO9823260 A3 WO 9823260A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
ionic surfactant
delivery agent
surfactant vesicles
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1997/003235
Other languages
English (en)
Other versions
WO1998023260A2 (fr
Inventor
Katharine Christine Carter
Alexander Balfour Mullen
Alan James Baillie
John Douglas Ansell
William Gerard Murphy
Kay Samuel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
University of Strathclyde
Common Services Agency for Scottish Health Service
Original Assignee
University of Edinburgh
University of Strathclyde
Common Services Agency for Scottish Health Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh, University of Strathclyde, Common Services Agency for Scottish Health Service filed Critical University of Edinburgh
Priority to JP52442098A priority Critical patent/JP2001510459A/ja
Priority to EP97945945A priority patent/EP0946148A2/fr
Publication of WO1998023260A2 publication Critical patent/WO1998023260A2/fr
Publication of WO1998023260A3 publication Critical patent/WO1998023260A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une formulation aqueuse (particulièrement sous forme injectable) contenant un polynucléotide et un constituant-entraîneur suspendus dans un véhicule aqueux. Cette formulation, bien que non exclusivement, contient de l'ADN ou de l'ARN combiné à des vésicules composées de tensioactifs non ioniques.
PCT/GB1997/003235 1996-11-26 1997-11-26 Vesicules de tensioactifs non ioniques en tant qu'agent de transport d'acide nucleique Ceased WO1998023260A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP52442098A JP2001510459A (ja) 1996-11-26 1997-11-26 核酸の放出剤としての非イオン性界面活性剤小胞
EP97945945A EP0946148A2 (fr) 1996-11-26 1997-11-26 Vesicules de tensioactifs non ioniques en tant qu'agent de transport d'acide nucleique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9624536.0 1996-11-26
GBGB9624536.0A GB9624536D0 (en) 1996-11-26 1996-11-26 Non-ionic surfactant vesicles as a delivery agent for nucleic acid

Publications (2)

Publication Number Publication Date
WO1998023260A2 WO1998023260A2 (fr) 1998-06-04
WO1998023260A3 true WO1998023260A3 (fr) 1998-08-27

Family

ID=10803479

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/003235 Ceased WO1998023260A2 (fr) 1996-11-26 1997-11-26 Vesicules de tensioactifs non ioniques en tant qu'agent de transport d'acide nucleique

Country Status (4)

Country Link
EP (1) EP0946148A2 (fr)
JP (1) JP2001510459A (fr)
GB (1) GB9624536D0 (fr)
WO (1) WO1998023260A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802422B1 (fr) * 1999-12-21 2002-08-09 Capsulis Structures mixtes resultant de l'incorporation d'une macromolecule biologique, en particulier d'adn, dans une phase structuree d'amphiphiles et vesicules obtenues a partir de ces structures
WO2009156706A1 (fr) * 2008-06-27 2009-12-30 University Of Strathclyde Délivrance pulmonaire de médicaments à l’aide de vésicules renfermant des surfactants non ioniques

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995016437A1 (fr) * 1993-12-17 1995-06-22 Micro-Pak, Inc. Procede de transmission, a une cellule, d'une substance a activite biologique
WO1996004890A1 (fr) * 1994-08-10 1996-02-22 University Of Strathclyde Formulation renfermant des vesicules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995016437A1 (fr) * 1993-12-17 1995-06-22 Micro-Pak, Inc. Procede de transmission, a une cellule, d'une substance a activite biologique
WO1996004890A1 (fr) * 1994-08-10 1996-02-22 University Of Strathclyde Formulation renfermant des vesicules

Also Published As

Publication number Publication date
JP2001510459A (ja) 2001-07-31
WO1998023260A2 (fr) 1998-06-04
GB9624536D0 (en) 1997-01-15
EP0946148A2 (fr) 1999-10-06

Similar Documents

Publication Publication Date Title
WO1995006731A3 (fr) Acide nucleique enzymatique contenant un non-nucleotide
AU2048899A (en) Surfactant systems for liquid aqueous preparations
EP1201562A3 (fr) Système de stockage compartimenté
EP1293565A3 (fr) Composante ARN de la télomérase de mammifères
AU6830200A (en) Non-ionic surfactant based aqueous multiphase cleaning agent
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
AU7401394A (en) In vivo nucleic acid hybridization method
ATA282485A (de) Stark schaeumendes, auf nichtionischen tensiden basierendes fluessiges feinreinigungsmittel und verfahren zu seiner herstellung
WO1997038010A3 (fr) Liposomes entrainant une fusion
AU9686798A (en) Mixing impellers especially adapted for use in surface aeration
AU7124398A (en) Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
AU9791398A (en) Liquid multipurpose-cleaning compositions with effective foam control
AU6298798A (en) Formulation of stabilized cationic transfection agent(s)/nucleic acid particles
WO1998023260A3 (fr) Vesicules de tensioactifs non ioniques en tant qu'agent de transport d'acide nucleique
CA2343528A1 (fr) Peinture pour l'etiquetage avec des stencils metalliques sur une ligne de finition de panneaux osb
CA2156439A1 (fr) Clathrates d'uree-surfactif et leur utilisation pour la bioregeneration de sols et d'eau contamines par les hydrocarbures
WO2003052720A3 (fr) Dispositif de publipostage direct
ATE131866T1 (de) Verfahren zur erhöhung des schüttgewichts sprühgetrockneter waschmittel
IT239829Y1 (it) Contenitore per attrezzi e martinetto di sollevamento per autoveicoli,particolarmente autovetture.
WO1997041243A3 (fr) Systeme d'expression cytoplasmique de gene mettant en application un autogene procaryote d'arn polymerase
WO1999055634A8 (fr) Additif superfluidifiant pour compositions a base de ciment
FR2744131B1 (fr) Systeme a base d'un agent tensio-actif non-ionique et d'un silicate de metal alcalin, sous forme d'une dispersion ou de granules et son utilisation en detergence
NZ295735A (en) Method for stabilizing enzymes in liquid compositions comprising forming an enzyme in an insoluble form and combining with an agent
AU2001275954A1 (en) System for delivering media messages to vehicle occupants and method of using the same
DE10080608D2 (de) System zur Blickfelderweiterung im KFZ

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997945945

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 524420

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998524420

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09308307

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1997945945

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997945945

Country of ref document: EP